TCTR20200518005已完成4 期
The effects of trimethoprim-sulfamethoxazole on the pharmacokinetic parameters of mycophenolate mofetil in healthy volunteers
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 16
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 40 Years（—）
- 性别
- All
入选标准
- •Healthy volunteers aged between 18-40 years with a creatinine clearance of >90 mL/min, ALT of <40 IU/L, AST of <35 IU/L, and serum albumin of >3.5 g/L.
排除标准
- •Known contraindication or hypersensitivity to mycophenolate mofetil, trimethoprim-sulfamethoxazole and other sulfa agents, such as sulfonamide or probenecid; known or suspected pregnancy or breast-feeding; chronic liver disease; hematological disorder; immunocompromised condition; taking antibiotics within 3 months prior to enrollment; regular consumption of alcohol, cigarette smoking, or recreational drugs use/addition.
研究者
相似试验
已完成
2 期
A study of role of trimethoprim-sulfamethoxazole in opportunistic infection prevention in lupus patients taking low-level immunosuppressive treatmentTrimethoprim-sulfamethoxazole primary prophylaxis in lupus patients taking low-level immunosuppressive treatmentLupusTrimethoprim-sulfamethoxazolePneumocystis pneumoniaSystemic lupus erythematosusTCTR20230606002Mahidol university138
已完成
不适用
Cotrimoxazol to prevent malaria in HIV-infected pregnant women in Sub-Saharan AfricaISRCTN98835811AlterSanté (France)300
已完成
不适用
A prospective study of Trimethoprime-sulfamethoxazole(TMP/SMX) for prevention of Pneumocystis pneumonia(PCP) in patients under immunosuppressive therapyThe patients with rheumatic diseases who are receiving more than 30mg/day of prednisoloneJPRN-UMIN000001647Division of Rheumatology,Department of Internal Medicine,Toho University School of Mdicine,Tokyo,Japan60
已完成
3 期
Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular ToxoplasmosisOcular ToxoplasmosisNCT01449877University of Campinas, Brazil141
已完成
不适用
Optimal regimens of sulfamethoxazole-trimethoprim for prophylaxis of pneumocystis pneumonia in patients with systemic rheumatic diseases: multi-center randomized open label trialPneumocystis pneumoniaJPRN-UMIN000031513Juntendo University School of Medicin89